<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Brain N-acetylaspartate (<z:chebi fb="8" ids="32918">NAA</z:chebi>) can be quantified by in vivo proton magnetic resonance spectroscopy (1H-MRS) and is used in clinical settings as a marker of neuronal density </plain></SENT>
<SENT sid="1" pm="."><plain>It is, however, uncertain whether the change in brain <z:chebi fb="8" ids="32918">NAA</z:chebi> content in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> is reliably measured by 1H-MRS and how <z:chebi fb="8" ids="32918">NAA</z:chebi> is distributed within the ischemic area </plain></SENT>
<SENT sid="2" pm="."><plain>Rats were exposed to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Preischemic values of [<z:chebi fb="8" ids="32918">NAA</z:chebi>] in striatum were 11 mmol/L by 1H-MRS and 8 mmol/kg by HPLC </plain></SENT>
<SENT sid="4" pm="."><plain>The methods showed a comparable reduction during the 8 hours of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The interstitial level of [<z:chebi fb="8" ids="32918">NAA</z:chebi>] ([<z:chebi fb="8" ids="32918">NAA</z:chebi>]e) was determined by microdialysis using [3H]<z:chebi fb="8" ids="32918">NAA</z:chebi> to assess in vivo recovery </plain></SENT>
<SENT sid="6" pm="."><plain>After induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, [<z:chebi fb="8" ids="32918">NAA</z:chebi>]e increased linearly from 70 micromol/L to a peak level of 2 mmol/L after 2 to 3 hours before declining to 0.7 mmol/L at 7 hours </plain></SENT>
<SENT sid="7" pm="."><plain>For comparison, [<z:chebi fb="8" ids="32918">NAA</z:chebi>]e was measured in striatum during global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, revealing that [<z:chebi fb="8" ids="32918">NAA</z:chebi>]e increased linearly to 4 mmol/L after 3 hours and this level was maintained for the next 4 h </plain></SENT>
<SENT sid="8" pm="."><plain>From the change in in vivo recovery of the interstitial space volume marker [<z:chebi fb="32" ids="36927">14C</z:chebi>]<z:chebi fb="1" ids="29864">mannitol</z:chebi>, the relative amount of <z:chebi fb="8" ids="32918">NAA</z:chebi> distributed in the interstitial space was calculated to be 0.2% of the total brain <z:chebi fb="8" ids="32918">NAA</z:chebi> during <z:mpath ids='MPATH_458'>normal</z:mpath> conditions and only 2 to 6% during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>It was concluded that the majority of brain <z:chebi fb="8" ids="32918">NAA</z:chebi> is intracellularly located during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> despite large increases of interstitial [<z:chebi fb="8" ids="32918">NAA</z:chebi>] </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> quantification of <z:chebi fb="8" ids="32918">NAA</z:chebi> during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reflects primarily changes in intracellular levels of <z:chebi fb="8" ids="32918">NAA</z:chebi> </plain></SENT>
</text></document>